Hereditary Cancer Testing Market to Reach US$ 9,840.52 Mn at a CAGR of 11.1% in 2027 | The Insight Partners

Hereditary Cancer Testing Market to 2027 - Global Analysis and Forecasts By Diagnosis Type (Biopsy, Imaging); Technology (Sequencing, PCR, Microarray); End User (Hospital, Clinics, Diagnostic Centers), and Geography

Publication Month: Sep 2019 | Report Code: TIPRE00006578 | No. of Pages: 171 | Category: Biotechnology | Status: Published

The global hereditary cancer testing market is US$ 3,967.74 Mn in 2018 and is predicted to grow at a CAGR of 11.1% during the forecast period 2019 – 2027, to reach US$ 9,840.52 Mn by 2027.

Asia Pacific is the fastest growing geographic market and is expected to be the significant revenue contributor in forecast period. The region has witnessed several technological advancements in the field of healthcare by the incorporation of advanced hereditary cancer screening for rising hereditary cancer prevalence in the region. There is a growing interest of international players in China and India, government support in countries such as China, and advancing healthcare infrastructure. Therefore, the region has huge potential for the hereditary cancer testing market players to grow during the forecast period.

 

Exhibit: Lucrative Regional Hereditary Cancer Testing Markets


 

Market Insights

Increasing Prevalence of Hereditary Cancer

Cancer is a genetic disorder caused due to definite variations in genes that govern cell functioning, particularly affecting their growth and replication. Hereditary genetic mutations are the cause of ~5–10% of all cancers. The researchers have related mutations in particular genes with more than 50 hereditary cancer syndromes affecting individuals in developing certain cancers. According to the World Health Organization, cancer caused ~9.6 million deaths worldwide in 2018. Further, as per the prediction of the National Cancer Institute, in 2018, ~1,735,350 new cancer cases would be diagnosed in the US. The increasing prevalence of breast cancer in the world is a huge concern. As per the World Health Organization, ~2.09 million cases of breast cancer were reported globally in 2018. However, according to breastcancer.org, in 2018, over 3.1 million women in the US were reported with a history of breast cancer. Furthermore, ~5–10% of breast cancers are related to the mutated genes inherited from parents. The variations in the BRCA1 and BRCA2 genes are prevalent. Women with a BRCA1 mutation have ~72% lifetime risk of developing breast cancer, while those with the BRCA2 mutation have ~69% risk of the same. Hence, with the rising occurrence of cancer, need for their early detection is also rising around the world. Hence, the increasing prevalence of cancer drives the steady growth of the hereditary cancer testing market.

 

Growing Awareness about Hereditary Cancer

Although, the genetic testing of various metabolic liabilities of cancer is clinically accessible, the available data suggest that a limited population is aware about these tests. The awareness regarding hereditary cancer conditions is growing due to various efforts made by the government. In the past decade, public medical, health, and scientific communities invested in spreading awareness regarding hereditary cancer conditions, with a major focus on hereditary cancer risk, family history, and genetic testing for inherited cancer liability. Direct-to-consumer (DTC) publicity of cancer genetic testing and federal regulations of genetic information have been other factors driving cancer genetic testing awareness among people. For instance, Myriad Genetics Laboratories, Inc. (Myriad), launched various DTC campaigns in major cities in US in the past decade. Moreover, multiple companies provide genomic profiling services for health assessment, including cancer risk prediction. Thus, increasing awareness regarding genetic cancer would enhance the demand for the diagnostic tests, along with improving the quality and efficacy of hereditary cancer testing during the forecast period.

Diagnosis Type Insights

The global hereditary cancer testing market by diagnosis type was led by imaging segment. In 2018, the imaging segment held a largest market share of the hereditary cancer testing market. This segment is also expected to dominate the market in 2027 owing to the trending inclination toward third-party service providers for hereditary cancer testing. The advantages of imaging such as, it is cost-effective, can be easily performed, and highly accurate are also propelling the growth of the segment.


Exhibit: Hereditary cancer testing Market, by Diagnosis Type

 

Strategic Insights

There have been limited developments made in the hereditary cancer testing market during recent years. However, growth strategies such as approvals, collaborations, and partnerships have been witnessed in the market of hereditary cancer testing. For instance, in February 2019, Hologic, Inc. received the CE Mark to the LOCalizer wireless radio frequency identification (RFID) breast lesion localization system. The approval enhances the portfolio of the company. Also, during October 2018, Cancer Genetics entered into collaboration with Cellaria, LLC. The aim of the collaboration is to manufacture precision medicine tools and platform technologies to support new cancer therapeutics.

 

HEREDITARY CANCER TESTING – MARKET SEGMENTATION

 

 BY DIAGNOSIS TYPE

  • Biopsy
    • Blood Sample
    • Cheek Swab Sample
  • Imaging

 

BY TECHNOLOGY

  • Sequencing
  • PCR
  • Microarray

 

BY END USER

  • Diagnostic Centers
  • Hospital
  • Clinics

 

BY GEOGRAPHY

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

 

  • Hologic Inc.
  • Koninklijke Philips N.V.
  • Quest Diagnostics Incorporated
  • Myriad Genetics, Inc.
  • Cancer Genetics Inc.
  • Invitae Corporation
  • Myogenes
  • Strand Life Sciences Pvt. Ltd.
  • Pathway Genomics Corporation
  • CENTOGENE AG

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Global Hereditary Cancer Testing Market – By Diagnosis Type

1.3.2        Global Hereditary Cancer Testing Market – By Technology

1.3.3        Global Hereditary Cancer Testing Market – By End User

1.3.4        Global Hereditary Cancer Testing Market – By Geography

2.             Global Hereditary Cancer Testing Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Global Hereditary Cancer Testing Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America PEST Analysis

4.2.2        Europe PEST Analysis

4.2.3        Asia Pacific PEST Analysis

4.2.4        Middle East & Africa PEST Analysis

4.2.5        South & Central America PEST Analysis

4.3       Expert Opinions

4.4       Hereditary Cancer Testing - Price Analysis (US$)

4.5       Reimbursement Scenario (US)

4.6       Population Screening Data

5.             Global Hereditary Cancer Testing Market – Key Industry Dynamics

5.1       Key Market Drivers

5.1.1        Increasing Prevalence of Hereditary Cancer

5.1.2        Growing Awareness About Hereditary Cancer

5.2       Key Market Restraints

5.2.1        Problems in Accessing Whole Genomic Data for Early Detection

5.3       Key Market Opportunities

5.3.1        Growing Demand for Noninvasive Methods of Detection

5.4       Future Trends

5.4.1        Preference For Personalized Medicines

5.5       Impact Analysis

6.             Hereditary Cancer Testing Market – Global Analysis

6.1       Global Hereditary Cancer Testing Market Revenue Forecasts And Analysis

6.2       Global Hereditary Cancer Testing Market, By Geography - Forecasts And Analysis

6.3       Performance of Key Players

7.             Global Hereditary Cancer Testing Market Analysis–  by Diagnosis Type

7.1       Overview

7.2       Global Hereditary Cancer Testing Market, By Diagnosis Type 2018 & 2027 (%)

7.3       Biopsy Market

7.3.1        Overview

7.3.2        Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.3        Blood Sample Market

7.3.3.1      Overview

7.3.3.2      Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)

7.3.4        Cheek Swab Sample Market

7.3.4.1      Overview

7.3.4.2      Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)

7.4       Imaging Market

7.4.1        Overview

7.4.2        Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

8.             Global Hereditary Cancer Testing Market Analysis–  by Technology

8.1       Overview

8.2       Global Hereditary Cancer Testing Market, By Technology 2018 & 2027 (%)

8.3       Sequencing Market

8.3.1        Overview

8.3.2        Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

8.4       Polymerase Chain Reaction (PCR) Market

8.4.1        Overview

8.4.2        Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)

8.5       Microarray Market

8.5.1        Overview

8.5.2        Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)

9.             Global Hereditary Cancer Testing Market Analysis –  by End User

9.1       Overview

9.2       Global Hereditary Cancer Testing Market, By End User 2018 & 2027 (%)

9.3       Diagnostic Centers Market

9.3.1        Overview

9.3.2        Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)

9.4       Hospitals Market

9.4.1        Overview

9.4.2        Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

9.5       Clinics Market

9.5.1        Overview

9.5.2        Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

10.          Hereditary Cancer Testing Market Revenue and Forecasts to 2027 – Geographical Analysis

10.1    North America Hereditary Cancer Testing Market

10.1.1     Overview

10.1.2     North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3     North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.1.3.1    North America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.1.4     North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

10.1.5     North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.6     North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

10.1.7     US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.1    US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.7.2    US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.1.7.2.1    US Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.1.7.3    US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.7.4    US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.8     Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1    Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.2    Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.1.8.2.1    Canada Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.1.8.3    Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.8.4    Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.1.9     Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.1    Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.2    Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.1.9.2.1    Mexico Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.1.9.3    Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.9.4    Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2    Europe Hereditary Cancer Testing Market

10.2.1     Overview

10.2.2     Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.3     Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.2.3.1    Europe Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.2.4     Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.2.5     Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.6     Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

10.2.7     UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.1    UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.7.2    UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.2.7.2.1    UK Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.2.7.3    UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.2.7.4    UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.8     Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.1    Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.8.2    Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.2.8.2.1    Germany Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.2.8.3    Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.2.8.4    Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.9     France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1    France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.2    France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.2.9.2.1    France Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.2.9.3    France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.2.9.4    France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.10   Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.1 Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.10.2 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.2.10.2.1 Italy Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.2.10.3 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.2.10.4 Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.2.11   Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.11.1 Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.11.2 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.2.11.2.1 Spain Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.2.11.3 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.2.11.4 Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3    Asia Pacific Hereditary Cancer Testing Market

10.3.1     Overview

10.3.2     Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.3     Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type  (US$ Mn)

10.3.3.1    Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.3.4     Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.3.5     Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.6     Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

10.3.7     China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.1    China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.7.2    China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.3.7.2.1    China Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.3.7.3    China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.3.7.4    China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.8     India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.1    India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.2    India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.3.8.2.1    India Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.3.8.3    India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.3.8.4    India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.9     Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.1    Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.9.2    Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.3.9.2.1    Japan Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.3.9.3    Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.3.9.4    Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.10   Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.1 Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.2 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.3.10.2.1 Australia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.3.10.3 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.3.10.4 Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.3.11   South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.11.1 South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.11.2 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.3.11.2.1 South Korea Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.3.11.3 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.3.11.4 South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4    Middle East & Africa Hereditary Cancer Testing Market

10.4.1     Overview

10.4.2     Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.3     Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.4.3.1    Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.4.4     Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.5     Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.6     Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

10.4.7     South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.1    South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.2    South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.4.7.2.1    South Africa Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.4.7.3    South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.7.4    South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.8     Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.1    Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.8.2    Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.4.8.2.1    Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.4.8.3    Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.8.4    Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.4.9     UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9.1    UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9.2    UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.4.9.2.1    UAE Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.4.9.3    UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.4.9.4    UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5    South And Central America Hereditary Cancer Testing Market

10.5.1     Overview

10.5.2     South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.3     South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.5.3.1    South and Central America Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.5.4     South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027,  By Technology (US$ Mn)

10.5.5     South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.6     South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027,  By Country (%)

10.5.7     Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.1    Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.7.2    Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.5.7.2.1    Argentina Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.5.7.3    Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.5.7.4    Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

10.5.8     Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8.1    Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8.2    Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

10.5.8.2.1    Brazil Hereditary Cancer Testing Market Revenue And Forecasts To 2027, By Biopsy (US$ Mn)

10.5.8.3    Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.5.8.4    Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

11.          Hereditary Cancer Testing Market – Industry Landscape

11.1    Overview

11.2    Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019

11.3    Organic Growth Strategies

11.3.1     Overview

11.3.2     Product Launch

11.3.3     Product Approval

11.3.4     Others

11.4    Inorganic Growth Strategies

11.4.1     Overview

11.4.2     Partnership

11.4.3     Agreement & Collaboration

11.4.4     Acquisition

12.          Hereditary Cancer Testing Market–Key Company Profiles

12.1    Hologic Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product Portfolio

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2    Koninklijke Philips N.V.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product Portfolio

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3    Quest Diagnostics Incorporated

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4    Myriad Genetics, Inc.

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Overview

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5    Cancer Genetics Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6    Invitae Corporation

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Overview

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7    Myogenes

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8    Strand Life Sciences Pvt. Ltd.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Overview

12.8.4     Product Portfolio

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9    Pathway Genomics Corporation

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Overview

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10 CENTOGENE AG

12.10.1   Key Facts

12.10.2   Business Description

12.10.3   Financial Overview

12.10.4   Product Portfolio

12.10.5   SWOT Analysis

12.10.6   Key Developments

13.          Appendix

13.1    About The Insight Partners

13.2    Glossary of Terms


LIST OF TABLES

Table 1.            CPT Codes for Hereditary Cancer Tests

Table 2.            North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 3.            North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 4.            North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 5.            North America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 6.            US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 7.            US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 8.            US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 9.            US Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 10.         Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 11.         Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 12.         Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 13.         Canada Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 14.         Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 15.         Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 16.         Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 17.         Mexico Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 18.         Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 19.         Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 20.         Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 21.         Europe Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 22.         UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 23.         UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 24.         UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 25.         UK Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 26.         Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 27.         Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 28.         Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 29.         Germany Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 30.         France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 31.         France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 32.         France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 33.         France Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 34.         Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 35.         Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 36.         Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 37.         Italy Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 38.         Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 39.         Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 40.         Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 41.         Spain Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 42.         Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 43.         Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 44.         Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 45.         Asia Pacific Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 46.         China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 47.         China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 48.         China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 49.         China Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 50.         India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 51.         India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 52.         India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 53.         India Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 54.         Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 55.         Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 56.         Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 57.         Japan Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 58.         Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 59.         Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 60.         Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 61.         Australia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 62.         South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 63.         South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 64.         South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 65.         South Korea Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 66.         Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type  (US$ Mn)

Table 67.         Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 68.         Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology  (US$ Mn)

Table 69.         Middle East & Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 70.         South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 71.         South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 72.         South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 73.         South Africa Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 74.         Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 75.         Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 76.         Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 77.         Saudi Arabia Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 78.         UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 79.         UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 80.         UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 81.         UAE Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 82.         South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 83.         South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy  (US$ Mn)

Table 84.         South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 85.         South and Central America Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 86.         Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 87.         Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 88.         Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 89.         Argentina Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 90.         Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Diagnosis Type (US$ Mn)

Table 91.         Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Biopsy (US$ Mn)

Table 92.         Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 93.         Brazil Hereditary Cancer Testing Market Revenue And Forecasts to 2027, By End User (US$ Mn)

Table 94.         Recent Product Launch in the Hereditary Cancer Testing Market

Table 95.         Recent Product Approval in the Hereditary Cancer Testing Market

Table 96.         Recent Other Growth Strategies in the Hereditary Cancer Testing Market

Table 97.         Partnerships in the Hereditary Cancer Testing Market

Table 98.         Agreement & Collaboration in the Hereditary Cancer Testing Market

Table 99.         Acquisitions in the Hereditary Cancer Testing Market

Table 100.       Glossary of Terms, Hereditary Cancer Testing Market


LIST OF FIGURES

Figure 1.          Hereditary Cancer Testing Market Segmentation

Figure 2.          Hereditary Cancer Testing Market Segmentation, by Region

Figure 3.          Global Hereditary Cancer Testing Market Overview

Figure 4.          Imaging Segment Held Largest Share Of The Diagnosis Type Segment In Hereditary Cancer Testing Market

Figure 5.          Asia Pacific Region Is Expected To Show Remarkable Growth During The Forecast Period

Figure 6.          Global Hereditary Cancer Testing Market, By Geography (US$ Mn)

Figure 7.          Global Hereditary Cancer Testing Market- Leading Country Markets (US$ Mn)

Figure 8.          Global Hereditary Cancer Testing Market, Industry Landscape

Figure 9.          North America : PEST Analysis

Figure 10.       Europe: PEST Analysis

Figure 11.       Asia - Pacific: PEST Analysis

Figure 12.       Middle East & Africa: PEST Analysis

Figure 13.       South & Central America: PEST Analysis

Figure 14.       Impact Analysis of Driver and Restraints Pertaining to Hereditary Cancer Testing Market

Figure 15.       Global Hereditary Cancer Testing Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 16.       Global Hereditary Cancer Testing Market – by Geography Forecasts and Analysis – 2018- 2027

Figure 17.       Prominent Players in the Hereditary Cancer Testing Market

Figure 18.       Global Hereditary Cancer Testing Market, by Diagnosis Type 2018 & 2027 (%)

Figure 19.       Global Biopsy Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 20.       Global Blood Sample Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 21.       Global Cheek Swab Sample Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 22.       Global Imaging Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 23.       Global Hereditary Cancer Testing Market, by Technology 2018 & 2027 (%)

Figure 24.       Global Sequencing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 25.       Global Polymerase Chain Reaction (PCR) Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 26.       Global Microarray Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 27.       Global Hereditary Cancer Testing Market, by End User 2018 & 2027 (%)

Figure 28.       Global Diagnostic Centers Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29.       Global Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 30.       Global Clinics Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31.       North America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)

Figure 32.       North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33.       North America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 34.       US Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35.       Canada Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 36.       Mexico Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37.       Europe Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)

Figure 38.       Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39.       Europe Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 40.       UK Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41.       Germany Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42.       France Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 43.       Italy Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 44.       Spain Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 45.       Asia Pacific Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)

Figure 46.       Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 47.       Asia Pacific Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 48.       China Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 49.       India Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 50.       Japan Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 51.       Australia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 52.       South Korea Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 53.       Middle East & Africa Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)

Figure 54.       Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 55.       Middle East & Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 56.       South Africa Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 57.       Saudi Arabia Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 58.       UAE Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 59.       South and Central America Hereditary Cancer Testing Market Revenue, by Country, 2018 (US$ Mn)

Figure 60.       South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 61.       South and Central America Hereditary Cancer Testing Market Revenue and Forecasts to 2027, By Country (%)

Figure 62.       Argentina Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 63.       Brazil Hereditary Cancer Testing Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 64.       Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019

Figure 65.       Organic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019

Figure 66.       Inorganic Growth Strategies in the Hereditary Cancer Testing Market, 2016-2019

The List of Companies

  1. Hologic Inc.
  2. Koninklijke Philips N.V.
  3. Quest Diagnostics Incorporated
  4. Myriad Genetics, Inc.
  5. Cancer Genetics Inc.
  6. Invitae Corporation
  7. Myogenes
  8. Strand Life Sciences Pvt. Ltd.
  9. Pathway Genomics Corporation
  10. CENTOGENE AG
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the hereditary cancer testing market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global hereditary cancer testing market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.